Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup

Publication | Closed Access

DOI

189

Citations

References

2002

Year

Esther Hauben, Simon Weeden, J Pringle, E A Van Marck, Pancras C.W. Hogendoorn

European Journal of Cancer

Surgical OncologyMedicineCancer ManagementMetronomic TherapyEuropean Osteosarcoma IntergroupConsecutive TrialsPathologyHistological SubtypeCancer TreatmentOncologyRadiation Oncology